Valuation: Supergenics

Market Cap 29.11M 7.15M 6.25M 5.74M 5.35M 10.16M 681M 10.31M 68.96M 26.81M 335M 26.84M 26.26M 1.15B P/E 2024
-9.45x
P/E 2025 -8.61x
Enterprise Value 32.5M 7.98M 6.98M 6.41M 5.98M 11.34M 760M 11.51M 77M 29.93M 374M 29.97M 29.32M 1.29B EV / Sales 2024
13.9x
EV / Sales 2025 5.78x
Free-Float
41.6%
Yield 2024 *
-
Yield 2025 -
1 year 0.2
Extreme 0.205
0.25
3 years 0.15
Extreme 0.15
0.6
5 years 0.15
Extreme 0.15
0.6
10 years 0.15
Extreme 0.15
0.6
Manager TitleAgeSince
Chief Executive Officer 48 2019-04-23
Corporate Secretary - 2022-06-01
Director TitleAgeSince
Director/Board Member 48 2019-04-23
Director/Board Member 60 2019-04-23
Director/Board Member 46 2022-01-27
Change 5-day change 1-year change 3-year change Capi.($)
+21.95%-.--%-16.67%+13.64% 7.15M
+1.70%+7.41%+2.50%+8.22% 49.92B
+0.92%+3.93%+399.71%+605.33% 40.23B
+1.89%+8.32%+26.06%-6.35% 34.55B
+2.38%+6.35%+21.25%+64.58% 33.09B
+3.96%+10.67%+8.30%+40.44% 27.51B
+2.51%+5.27% - - 17.05B
+2.58%+5.79%+73.44%+133.27% 15.92B
+0.32%+0.58%+14.00%+19.59% 13.86B
+3.30%+0.76%+90.23%+99.12% 13.52B
Average +4.15%+5.24%+68.76%+108.65% 24.57B
Weighted average by Cap. +2.07%+6.53%+90.20%+137.90%

Financials

2024 2025
Net sales 5.32M 1.31M 1.14M 1.05M 979K 1.86M 124M 1.88M 12.61M 4.9M 61.18M 4.91M 4.8M 211M 5.63M 1.38M 1.21M 1.11M 1.03M 1.96M 132M 1.99M 13.33M 5.18M 64.67M 5.19M 5.08M 223M
Net income -7.28M -1.79M -1.56M -1.44M -1.34M -2.54M -170M -2.58M -17.25M -6.71M -83.7M -6.71M -6.57M -288M -3.37M -827K -723K -664K -619K -1.17M -78.71M -1.19M -7.97M -3.1M -38.69M -3.1M -3.04M -133M
Net Debt 4.48M 1.1M 961K 883K 823K 1.56M 105M 1.59M 10.61M 4.12M 51.47M 4.13M 4.04M 177M 3.39M 834K 729K 670K 624K 1.18M 79.38M 1.2M 8.04M 3.13M 39.02M 3.13M 3.06M 134M
Logo Supergenics
Supergenics Berhad is a Malaysia-based management and investment holding company. The Company operates through three segments: Integrated Turnkey Solutions, Biomedical, and Investment Holding. Its Integrated Turnkey Solutions segment is engaged in the provision of integrated turnkey solutions for the related development of cleanrooms and the provision of related maintenance services. Its Biomedical segment is engaged in the provision of administrative health care services, operating medical laboratories, and developing regenerative wellness products. The Company provides laboratory services, including storage and handling of stem cell samples. Its services include stem cells, mesenchymal stem cells (MSC), natural killer (NK) cells, exosomes, and MSC exosomes. Its subsidiaries include Supergenics Solution Sdn. Bhd., Supergenics Life Science Sdn. Bhd., Supergenics Therapeutic Sdn. Bhd., Supergenics Bio Agro Sdn. Bhd., Supergenics Stembank Sdn. Bhd., and Supergenics Global Sdn. Bhd.
Employees
-
  1. Stock Market
  2. Stocks
  3. 03033 Stock